Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 4 hours ago
Withdrawn application: DuoResp Spiromax, 27/04/2026
about 4 hours ago
Withdrawn application: DuoResp Spiromax, 27/04/2026
Guideline on data requirements for authorisation of immunological veterinary medicinal products in exceptional circumstances - Scientific guideline
about 4 hours ago
Guideline on data requirements for authorisation of immunological veterinary medicinal products in...
Withdrawn application: BiResp Spiromax, 27/07/2026
about 4 hours ago
Withdrawn application: BiResp Spiromax, 27/07/2026
HMA-EMA Network Data Steering Group: membership list
about 6 hours ago
HMA-EMA Network Data Steering Group: membership list
Step-by-step guide : Support with workload management in the authority workspace - CTIS Training Programme - Module 04
about 6 hours ago
Step-by-step guide : Support with workload management in the authority workspace -...
Clinical Trial Information System (CTIS) - Sponsor handbook
about 6 hours ago
Clinical Trial Information System (CTIS) - Sponsor handbook
FAQs: Support with workload management by workspace - CTIS Training Programme - Module 04
about 6 hours ago
FAQs: Support with workload management by workspace - CTIS Training Programme -...
Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026
about 8 hours ago
Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation...
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
about 8 hours ago
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion
about 8 hours ago
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion
about 8 hours ago
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion